Medpace

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.

CEO

August James Troendle

CEOAugust James Troendle

Employees

6,200

Employees6,200

Headquarters

Cincinnati, Ohio

HeadquartersCincinnati, Ohio

Founded

1992

Founded1992

Employees

6,200

Employees6,200

MEDP Key Statistics

Market cap

17.37B

Market cap17.37B

Price-Earnings ratio

33.85

Price-Earnings ratio33.85

Dividend yield

—

Dividend yield—

Average volume

504.41K

Average volume504.41K

High today

$589.37

High today$589.37

Low today

$570.34

Low today$570.34

Open price

$589.37

Open price$589.37

Volume

249.45K

Volume249.45K

52 Week high

$677.90

52 Week high$677.90

52 Week low

$373.00

52 Week low$373.00

Stock Snapshot

With a market cap of 17.37B, Medpace(MEDP) trades at $576.00. The stock has a price-to-earnings ratio of 33.85.

As of 2026-08-04, Medpace(MEDP) stock has fluctuated between $570.34 and $589.37. The current price stands at $576.00, placing the stock +1.0% above today's low and -2.3% off the high.

Medpace(MEDP) shares are trading with a volume of 249.45K, against a daily average of 504.41K.

During the past year, Medpace(MEDP) stock moved between $373.00 at its lowest and $677.90 at its peak.

MEDP News

TipRanks 4d

Medpace Backs Shockwave’s New Carotid Device Study, Signaling Fresh Upside in Vascular Innovation

Medpace Holdings Inc (MEDP) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

Simply Wall St 4d

Have Medpace Holdings Insiders Been Selling Stock?

We wouldn't blame Medpace Holdings, Inc. ( ) shareholders if they were a little worried about the fact that Susan Burwig, a company insider, recently netted abo...

Simply Wall St 5d

Medpace Holdings Is Up 10.8% After Boosting 2026 Outlook And Retiring 17% Of Shares - Has The Bull Case Changed?

Medpace Holdings, Inc. recently reported second-quarter 2026 results showing higher sales and net income than a year earlier, and it completed a US$1.57 billion...

Analyst ratings

73%

of 15 ratings

Buy

13.3%

Hold

73.3%

Sell

13.3%

More MEDP News

TipRanks 5d

Top Medpace Insiders Quietly Cash Out Millions in High-Profile Stock Moves

New insider activity at Medpace Holdings ( (MEDP) ) has taken place on July 29, 2026. Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premi...

TipRanks 7d

LIBerate-Kids: Medpace Backs New Pediatric Cholesterol Study With Lerodalcibep

Medpace Holdings Inc (MEDP) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.